The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
William Maughan is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/27/2024 | BNTX | Buy Now | BioNTech | $95.90 | 78.77% | William Maughan71% | $171 → $171.44 | Maintains | Buy | Get Alert |
09/14/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | William Maughan71% | $80 → $40 | Maintains | Buy | Get Alert |
04/03/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | William Maughan71% | $160 → $80 | Maintains | Buy | Get Alert |
03/31/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.84 | 271.9% | William Maughan71% | $20 → $18 | Maintains | Buy | Get Alert |
03/28/2023 | BNTX | Buy Now | BioNTech | $95.90 | 111.68% | William Maughan71% | $191 → $203 | Maintains | Buy | Get Alert |
02/24/2023 | XNCR | Buy Now | Xencor | $10.62 | 295.48% | William Maughan71% | $48 → $42 | Maintains | Buy | Get Alert |
11/15/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | William Maughan71% | $200 → $20 | Downgrade | Buy → Hold | Get Alert |
10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.84 | 457.85% | William Maughan71% | $35 → $27 | Maintains | Buy | Get Alert |
07/06/2022 | OLMA | Buy Now | Olema Pharmaceuticals | $4.14 | 286.47% | William Maughan71% | → $16 | Assumes | → Buy | Get Alert |
07/06/2022 | XNCR | Buy Now | Xencor | $10.62 | 370.81% | William Maughan71% | → $50 | Assumes | → Buy | Get Alert |
07/06/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | William Maughan71% | → $200 | Assumes | → Buy | Get Alert |
07/06/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | William Maughan71% | → $160 | Assumes | → Buy | Get Alert |
07/06/2022 | BNTX | Buy Now | BioNTech | $95.90 | 100.21% | William Maughan71% | → $192 | Assumes | → Buy | Get Alert |
07/06/2022 | BCYC | Buy Now | Bicycle Therapeutics | $8.73 | 587.29% | William Maughan71% | → $60 | Assumes | → Buy | Get Alert |
04/05/2022 | BNTX | Buy Now | BioNTech | $95.90 | 212.83% | William Maughan71% | $450 → $300 | Maintains | Buy | Get Alert |
08/20/2021 | BNTX | Buy Now | BioNTech | $95.90 | 369.24% | William Maughan71% | $240 → $450 | Maintains | Buy | Get Alert |
05/13/2021 | BNTX | Buy Now | BioNTech | $95.90 | 150.26% | William Maughan71% | $130 → $240 | Maintains | Buy | Get Alert |
12/14/2020 | BNTX | Buy Now | BioNTech | $95.90 | 35.56% | William Maughan71% | $115 → $130 | Maintains | Buy | Get Alert |
12/14/2020 | OLMA | Buy Now | Olema Pharmaceuticals | $4.14 | 1349.28% | William Maughan71% | → $60 | Initiates | → Buy | Get Alert |
11/12/2020 | BNTX | Buy Now | BioNTech | $95.90 | 19.92% | William Maughan71% | $112 → $115 | Maintains | Buy | Get Alert |
11/10/2020 | BNTX | Buy Now | BioNTech | $95.90 | 16.79% | William Maughan71% | $97 → $112 | Maintains | Buy | Get Alert |
07/21/2020 | BNTX | Buy Now | BioNTech | $95.90 | 1.15% | William Maughan71% | $75 → $97 | Maintains | Buy | Get Alert |
07/13/2020 | BNTX | Buy Now | BioNTech | $95.90 | -21.79% | William Maughan71% | $60 → $75 | Maintains | Buy | Get Alert |
04/03/2020 | BNTX | Buy Now | BioNTech | $95.90 | -37.43% | William Maughan71% | $22 → $60 | Reiterates | → Buy | Get Alert |
11/04/2019 | BNTX | Buy Now | BioNTech | $95.90 | -77.06% | William Maughan71% | → $22 | Initiates | → Buy | Get Alert |
08/08/2019 | XNCR | Buy Now | Xencor | $10.62 | 389.64% | William Maughan71% | $45 → $52 | Maintains | Buy | Get Alert |
05/09/2018 | XNCR | Buy Now | Xencor | $10.62 | 257.82% | William Maughan71% | $36 → $38 | Maintains | Buy | Get Alert |
11/23/2016 | XNCR | Buy Now | Xencor | $10.62 | 201.32% | William Maughan71% | $27 → $32 | Maintains | Buy | Get Alert |
12/22/2015 | XNCR | Buy Now | Xencor | $10.62 | — | William Maughan71% | — | Initiates | → Buy | Get Alert |